- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/36 - Allergens from pollen
Patent holdings for IPC class A61K 39/36
Total number of patents in this class: 240
10-year publication summary
|
27
|
12
|
11
|
16
|
8
|
13
|
11
|
15
|
6
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ALK-Abelló A/S | 130 |
17 |
| Selecta Biosciences, Inc. | 173 |
15 |
| Lofarma S.p.A. | 40 |
12 |
| Circassia Limited | 35 |
9 |
| La Jolla Institute for Allergy and Immunology | 98 |
9 |
| Université Paris Cité | 875 |
9 |
| The Board of Trustees of the Leland Stanford Junior University | 6600 |
6 |
| Biomay AG | 21 |
6 |
| Desentum Oy | 13 |
6 |
| Immunomic Therapeutics, Inc. | 34 |
6 |
| Anergis S.A. | 5 |
5 |
| Zonhon Biopharma Institute Inc. | 47 |
5 |
| Stallergenes SA | 14 |
5 |
| Assistance Publique - Hopitaux de Paris | 1031 |
4 |
| Phadia AB | 86 |
4 |
| Worg Pharmaceuticals (Zhejiang) Co., Ltd. | 25 |
4 |
| The Regents of the University of Michigan | 4918 |
3 |
| Biotech Tools S.A. | 6 |
3 |
| Daiichi Sankyo Company, Limited | 1886 |
3 |
| Stallergenes | 71 |
3 |
| Other owners | 106 |